⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

January 1, 2011Journal of Molecular DiagnosticsOpen Access

Laboratory Guidelines for Detection, Interpretation, and Reporting of Maternal Cell Contamination in Prenatal Analyses

Narasimhan Nagan Nicole Faulkner Christine A. Curtis Iris Schrijver

View Full Paper

Ask AI

Bookmark

Share

Abstract

This document summarizes laboratory guidelines for the detection, interpretation, and reporting of maternal cell contamination in prenatal analyses.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Nagan et al. (2011) studied this question.

synapsesocial.com/papers/6ab21e170d959410ec971efc https://doi.org/10.1016/j.jmoldx.2010.11.013

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Maternal cell contamination of prenatal samples assessed by QF-PCR genotypingCohort Study · 2005 · 69 citations
2MATERNAL CELL CONTAMINATION IN UNCULTURED AMNIOTIC FLUIDOriginal Research · 1996 · 60 citations
3Some caveats in PCR-based prenatal diagnosis on direct amniotic fluid versus cultured amniocytesOriginal Research · 1999 · 18 citations
4Detection of maternal cell contamination in amniotic fluid cell cultures using fluorescent labelled microsatellites.Original Research · 1995 · 28 citations
5Molecular Basis of Sarcomeric Variants and the Modifying Role of Non-sarcomeric Genes in Sudden Unexplained Nocturnal Death Syndrome (SUNDS)Journal of Molecular Diagnostics · Tue,

More from Journal of Molecular Diagnostics

The effect of unique molecular identifier family size using tumor-informed circulating tumor-DNA analysis in childhood cancersTue,
Parallel Analysis of Repeat ExpansionsTue,
Toward a Robust Cell-free DNA Isolation Protocol for Next-Generation Sequencing Applications in a Clinical Molecular Diagnostics SettingTue,
Highly Accurate Detection of Circulating Tumor DNA for Monitoring Minimal Residual Disease in Solid Tumors: Analytical and Clinical Validation of the Haystack MRD AssaySat,
Utilization of Next-Generation Sequencing (NGS) in Unexplained Cytopenia: Development and Validation of a Predictive Model to Guide Selective Use of Myeloid NGSSat,